Am J Transplant, Volume 17, Suppl 3 Archives - Page 12 of 181 - ATC Abstracts

2017 American Transplant Congress
Perceived Patient Barriers for Kidney Transplant Evalution Among Transplant Center Staff.
L. McPherson, K. Lipford, R. Hamoda, J. Gander, S. Pastan, R. Patzer.
Emory University, Atlanta, GA
Background: The Southeastern United States has the lowest rates of kidney transplant in the nation. Disparities in transplant access among end stage renal disease (ESRD)…
2017 American Transplant Congress
Lung Preservation Solution Exposure at Cardiac Procurement Is Associated Increased Incidence of Coronary Arterial Vasculopathy.
H. Copeland,¹ V. Garcia,² A. Sima,² D. Baran,³ A. Mankind,⁴ G. Katlaps,¹ N. Lewis,⁴ B. Dharmaj,¹ J. Copeland.⁵
¹Cardiothoracic Surgery, McGuire VA Medical Center, Richmond, VA; ²Biostatistics, Virginia Commonwealth University, Richmond, VA; ³Cardiology, Beth Israel Medical Center Barnabas Health, Newark, NJ; ⁴Cardiology, McGuire VA Medical Center, Richmond, VA; ⁵Surgery, Division of Cardiothoracic Surgery, University of Arizona, Tucson, AZ
Purpose: To evaluate cardiac recipient survival and incidence of coronary artery vasculopathy (CAV) in recipient hearts that have been exposed to lung preservation solution, Perfadex.Methods:…
2017 American Transplant Congress
Exploring Differential Antibody Response to Bortezomib in Heart Transplantation.
K. Ghafourian, R. Hod-Dvorai, S. McCabe, N. Cool, M. Fine, M. Ackerman, J. Rich, J. Wilcox, E. Vorovich, A. Anderson, A. Tambur.
Northwestern University, Chicago, IL
Twelve heart transplant candidates (2013-2016) received Bortezomib (BTZ) for desensitization. Differential antibody (Ab) response was observed. BTZ cycles consisted of 4 injections of 1.3 mg/m2;…
2017 American Transplant Congress
M1 Macrophage-Induced Loss of KLF15 Promotes Chronic Podocyte Injury.
S. Han,^1,2 Y. Kim,¹ S. Lee,¹ H. Lee,^1,2 R.-H. Cha,² J. Lee,^1,2 J. Lee,² D. Kim,^1,2 Y. Kim,^1,2 S. Yang.^1,2
¹Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ²Kidney Research Institute, Seoul National University, Seoul, Korea
Background: Krüppel-like factor 15 (KLF15), kidney-enriched transcription factor, is known to participate in the differentiation of podocyte. However, the implication of KLF15 in chronic podocyte…
2017 American Transplant Congress
Renal Transplant Recipients with Indication for Antiplatelet Therapy: Increased Risk for the Allograft?
T. Benko, M. Gottmann, S. Radunz, J. Treckmann, F. Saner, A. Paul, D. Hoyer.
General Visceral and Transplantation Surgery, University Hospital, Essen, Germany
Background Antiplatelet therapy is common in patients on the waiting list for kidney transplantation increasing the risk for perioperative blood loss. This study evaluates the…
2017 American Transplant Congress
Is There a [bdquo]Weekend Effect“ in Kidney Transplantation? – A Single Center Study.
K. Schütte-Nütgen, G. Thölking, H. Pavenstädt, B. Suwelack, S. Reuter.
Department of Internal Medicine D, University Hospital Münster, Münster, Germany
The "weekend effect" describes increased adverse events and outcomes for patients hospitalized on weekends due to limited resources at hospitals and - in the context…
2017 American Transplant Congress
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.
A. Cavalcanti,¹ M. Durao,^1,2 B. Santos,^1,2 E. Tonato,^1,2 M. Doher,² N. Guimaraes-Souza,^1,2 L. Moreira Valle,¹ B. Affonso,¹ F. Nasser,¹ A. Pacheco-Silva.^1,2
¹Nephrology, Hospital Israelita Albert Einstein, São Paulo, Brazil; ²Nephrology, Universidade Federal de São Paulo, São Paulo, Brazil
Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…
2017 American Transplant Congress
Status 1 Liver Transplantation: Changes in Characteristics and Outcome Over Time.
H. Truong, L. Lacar, L. Wong.
General Surgery, University of Hawaii, JABSOM, Honolulu, HI
Purpose: Approximately 5% of liver transplants (LT) annually require this urgently as “Status 1." The aim of this study is to characterize patients who received…
2017 American Transplant Congress
Is It Safe to Use Older Donor Liver Grafts for Older Recipients?
M. Safwan, K. Collins, K. Takahashi, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
Aim: The safety of liver transplantation (LT) using older donor grafts into older recipients remains to be elucidated. The aim of this study was to…
2017 American Transplant Congress
Association of BK and CMV Viremia with Pancreas Allograft Survival Among Adults Receiving Simultaneous Pancreas and Kidney Transplant: The Wisconsin Allograft Recipient Database (WisARD).
F. Aziz, B. Astor, S. Parajuli, N. Garg, B. Muth, D. Mandelbrot, A. Djamali, D. Kaufman, J. Odorico, H. Sollinger, M. Mohamed.
Department of Medicine, University of Wisconsin, Madison, WI
Knowing impact of BKV viremia and CMV infection on pancreas allograft outcome post Simultaneous Pancreas and Kidney transplant (SPK) may improve allograft long-term survival and…